Transforming the way medical research is funded by investing in early-career researchers with innovative ideas.
10-Year Charleston Conference on Alzhiemer's Disease Reunion
The Charleston Conference on Alzheimer's Disease
The Charleston Conference on Alzheimer’s Disease (CCAD) is a new approach to funding research of the most common cause of dementia in older adults, Alzheimer’s disease (AD). CCAD joins established scientists with early-career investigators to support novel research ideas, foster cross-field collaboration, and create a forum for constructive criticism. The format of CCAD encourages innovative thinking by providing financial support to a select few early-career investigators whose promising studies push the frontiers of Alzheimer’s disease research.
![](https://newvisionresearch.org/wp-content/uploads/2020/11/network-300x242.png)
Support early-career investigators
CCAD educates scientists on the NIH grant review process through staging mock NIH study sections.
![](https://newvisionresearch.org/wp-content/uploads/2020/11/Untitled-1-1-300x242.png)
Encourage risk and inspire new thinking
CCAD Funds innovative ideas that may not typically receive funding through conventional channels.
![](https://newvisionresearch.org/wp-content/uploads/2020/11/encourage-risk-300x242.png)
Foster cross-field collaboration
CCAD provides opportunities for early-career scientists to network and collaborate.